Guru Ownership Trend
Guru Analysis for Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $45.13 M.
Top institutional holders include Steven Cohen and Stanley Druckenmiller.
Institutional sentiment is currently Bullish. This is evidenced by a $33.92 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 175.8%. Conversely, Chuck Royce reduced exposure by 10.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Definium Therapeutics, Inc. (DFTX)
Major holders include Steven Cohen ($22.77 M), Stanley Druckenmiller ($16.77 M), Chuck Royce ($9.81 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $33.92 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DFTX. The total reported sell value was $1.2 M.
Yes, 2 managers opened new positions in DFTX, and 2 increased their existing holdings. The total reported buy value was $35.12 M.